Vol 10, No 2 (2018)
Mol Cell Pharmacol
Table of Contents
FDA Corner
| FDA Approves Novel Preventive Treatment for Migraine | Abstract PDF |
| 5 |
| FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy | Abstract PDF |
| 5-6 |
| FDA Approves First-of-its Kind Targeted RNA-based Therapy to Treat a Rare Disease | Abstract PDF |
| 6-8 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.